Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer.

Jeetle, SS; Fisher, G; Yang, ZH; Stankiewicz, E; Møller, H; Cooper, CS; Cuzick, J; Berney, DM; Trans-Atlantic Prostate Group; (2012) Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer. Virchows Archiv, 461 (2). pp. 103-7. ISSN 0945-6317 DOI: https://doi.org/10.1007/s00428-012-1259-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1007/s00428-012-1259-2

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar